Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-27

FDA Approved: RANOLAZINE — Original Application (A2A Integrated Pharmaceuticals)

View source ↗

Summary

FDA approves the original ANDA for Ranolazine submitted by A2A Integrated Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)